Matthias Eikermann Selected Research

Neostigmine (Neostigmine Bromide)

1/2020	The effects of acetylcholinesterase inhibitors on morbidity after general anesthesia and surgery.
1/2020	Effects of Anticholinesterase Reversal Under General Anesthesia on Postoperative Cardiovascular Complications: A Retrospective Cohort Study.
11/2018	Comparison of a novel clinical score to estimate the risk of REsidual neuromuscular block Prediction Score and the last train-of-four count documented in the electronic anaesthesia record: A retrospective cohort study of electronic data on file.
1/2016	Reversing neuromuscular blockade: inhibitors of the acetylcholinesterase versus the encapsulating agents sugammadex and calabadion.
12/2014	Residual Paralysis: Does it Influence Outcome After Ambulatory Surgery?
11/2014	Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study.
12/2010	Neostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Eikermann Research Topics

Disease

9	Muscle Weakness 01/2020 - 01/2007
8	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 05/2008
8	Pain (Aches) 01/2021 - 12/2003
7	Delayed Emergence from Anesthesia 01/2020 - 03/2006
6	Hypotension (Low Blood Pressure) 11/2021 - 04/2012
5	Neoplasms (Cancer) 07/2022 - 02/2003
5	Critical Illness (Critically Ill) 10/2020 - 04/2011
4	Nausea 07/2022 - 12/2018
4	Delirium 06/2022 - 01/2019
4	Paralysis (Palsy) 10/2020 - 05/2005
4	Hypoxia (Hypoxemia) 01/2020 - 05/2008
4	Sleep Apnea Syndromes (Sleep Apnea) 01/2018 - 07/2016
4	Obstructive Sleep Apnea 01/2018 - 06/2010
3	Vomiting 07/2022 - 12/2018
3	Heart Failure 06/2022 - 12/2020
3	Ischemic Stroke 01/2021 - 01/2017
3	Migraine Disorders (Migraine) 12/2020 - 01/2017
3	Wounds and Injuries (Trauma) 10/2020 - 04/2013
3	Airway Obstruction (Choking) 01/2020 - 03/2006
3	Body Weight (Weight, Body) 01/2018 - 06/2010
3	Apnea 01/2018 - 07/2016
2	Hyperglycemia 07/2022 - 11/2021
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 01/2021
2	Bradycardia 10/2020 - 01/2020
2	Deglutition Disorders (Dysphagia) 01/2020 - 01/2007
2	Acidosis 01/2020 - 04/2012
2	Treatment-Resistant Depressive Disorder 01/2019 - 01/2017
2	Opioid-Related Disorders (Opiate Addiction) 01/2018 - 02/2003
2	Hypercapnia 12/2014 - 05/2008
2	Pulmonary Edema 11/2014 - 11/2011
2	Infections 08/2014 - 12/2003
1	Surgical Wound Infection 07/2022
1	Confusion (Bewilderment) 06/2022
1	Acute Disease 06/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Diabetes Mellitus 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Anemia 11/2021
1	Intracranial Aneurysm (Cerebral Aneurysm) 10/2021
1	Ischemia 10/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	COVID-19 01/2021
1	Coma (Comas) 01/2021
1	Stroke (Strokes) 01/2021
1	Infarction (Infarctions) 01/2021
1	Postoperative Pain 12/2020
1	Tachycardia (Tachyarrhythmias) 01/2020
1	Atrial Fibrillation 01/2020
1	Hypoventilation 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Muscle Rigidity 01/2020

Drug/Important Bio-Agent (IBA)

11	Opioid Analgesics (Opioids)IBA 01/2021 - 02/2003
9	Neuromuscular Blocking AgentsIBA 01/2021 - 06/2007
7	Neostigmine (Neostigmine Bromide)IBA 01/2020 - 12/2010
6	Propofol (Diprivan)FDA LinkGeneric 01/2022 - 05/2008
5	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 12/2009
4	Anesthetics (Anesthetic Agents)IBA 10/2021 - 03/2006
4	Ketamine FDA LinkGeneric 08/2019 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2022 - 07/2009
3	Midodrine (Midon)FDA LinkGeneric 01/2021 - 01/2017
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020 - 12/2010
3	Analgesics (Analgesic Drugs)IBA 08/2019 - 12/2003
3	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 12/2003
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2022 - 12/2018
2	Hemoglobins (Hemoglobin)IBA 11/2021 - 03/2016
2	Antidepressive Agents (Antidepressants)IBA 12/2020 - 01/2019
2	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2020 - 01/2019
2	Rocuronium (Zemuron)FDA LinkGeneric 07/2009 - 05/2005
1	Carbon MonoxideIBA 06/2022
1	BenzodiazepinesIBA 01/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2021
1	Etomidate FDA LinkGeneric 12/2020
1	Type A Botulinum Toxins (Botox)FDA Link 12/2020
1	Ergotamine (Ergotamine Tartrate)FDA LinkGeneric 12/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2020
1	Tryptamines (Triptans)IBA 12/2020
1	Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric 10/2020
1	cucurbit(n)uril (cucurbituril)IBA 01/2020
1	suvorexantIBA 01/2020
1	calabadion 1IBA 01/2020
1	Orexin Receptor AntagonistsIBA 01/2020
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2020
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2020

Therapy/Procedure

10	Anesthesia 07/2022 - 05/2008
10	Length of Stay 11/2021 - 04/2012
8	Artificial Respiration (Mechanical Ventilation) 01/2022 - 04/2013
6	Analgesia 01/2021 - 12/2003
5	Critical Care (Surgical Intensive Care) 08/2019 - 09/2009
4	Therapeutics 07/2022 - 12/2003
4	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022 - 11/2011
4	Patient Readmission 12/2020 - 01/2017
3	General Anesthesia 01/2022 - 02/2003
2	Perioperative Period 12/2020 - 01/2019
2	Epidural Analgesia 02/2005 - 12/2003
1	Tracheostomy 06/2022
1	Home Nursing (Nursing, Home) 01/2022
1	Deep Sedation 01/2022
1	Conduction Anesthesia (Regional Anesthesia) 01/2021
1	Drug Prescriptions 12/2020